Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR
- PMID: 23211132
- DOI: 10.1016/j.antiviral.2012.11.008
Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR
Abstract
West Nile virus (WNV) NS2B-NS3 protease is an important drug target since it is an essential protein for the replication of the virus. In order to determine the minimum pharmacophore for protease inhibition, a series of dipeptide aldehydes were synthesized. The 50% inhibitory concentration (IC(50)) measurements revealed that a simple acetyl-KR-aldehyde was only threefold less active than 4-phenyl-phenylacetyl-KKR-aldehyde (1) (Stoermer et al., 2008) that was used as the reference compound. The ligand efficiency of 0.40 kcal/mol/HA (HA=heavy atom) for acetyl-KR-aldehyde is much improved compared to the reference compound 1 (0.23 kcal/mol/HA). The binding of the inhibitors was examined using (1)H-(15)N-HSQC experiments and differential chemical shifts were used to map the ligand binding sites. The biophysical studies show that the conformational mobility of WNV protease has a major impact on the design of novel inhibitors, since the protein conformation changes profoundly depending on the structure of the bound ligand.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.Nat Struct Mol Biol. 2006 Apr;13(4):372-3. doi: 10.1038/nsmb1073. Epub 2006 Mar 12. Nat Struct Mol Biol. 2006. PMID: 16532006
-
West Nile Virus (WNV) protease and membrane interactions revealed by NMR spectroscopy.Biochem Biophys Res Commun. 2012 Jul 13;423(4):799-804. doi: 10.1016/j.bbrc.2012.06.043. Epub 2012 Jun 16. Biochem Biophys Res Commun. 2012. PMID: 22713461
-
Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.J Mol Recognit. 2010 May-Jun;23(3):283-300. doi: 10.1002/jmr.977. J Mol Recognit. 2010. PMID: 19693793
-
West Nile Virus NS2B/NS3 protease as an antiviral target.Curr Med Chem. 2008;15(27):2771-84. doi: 10.2174/092986708786242804. Curr Med Chem. 2008. PMID: 18991636 Review.
-
Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.Antiviral Res. 2008 Nov;80(2):94-101. doi: 10.1016/j.antiviral.2008.07.001. Epub 2008 Jul 30. Antiviral Res. 2008. PMID: 18674567 Review.
Cited by
-
Targeting the protease of West Nile virus.RSC Med Chem. 2021 May 26;12(8):1262-1272. doi: 10.1039/d1md00080b. eCollection 2021 Aug 18. RSC Med Chem. 2021. PMID: 34458734 Free PMC article. Review.
-
Solution NMR Spectroscopy in Target-Based Drug Discovery.Molecules. 2017 Aug 23;22(9):1399. doi: 10.3390/molecules22091399. Molecules. 2017. PMID: 28832542 Free PMC article. Review.
-
NMR as a "Gold Standard" Method in Drug Design and Discovery.Molecules. 2020 Oct 9;25(20):4597. doi: 10.3390/molecules25204597. Molecules. 2020. PMID: 33050240 Free PMC article. Review.
-
Mechanisms of Action for Small Molecules Revealed by Structural Biology in Drug Discovery.Int J Mol Sci. 2020 Jul 24;21(15):5262. doi: 10.3390/ijms21155262. Int J Mol Sci. 2020. PMID: 32722222 Free PMC article. Review.
-
Dengue virus NS4B protein as a target for developing antivirals.Front Cell Infect Microbiol. 2022 Aug 9;12:959727. doi: 10.3389/fcimb.2022.959727. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36017362 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
